LTRN
Lantern Pharma Inc
0.8601$
-14.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | +0.0% | -100.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | +1,812.1% | – | – | -46.4% | +1.0% | +1.5% | -0.5% | +11.7% | +0.7% | -1.0% | +2.3% | +1.9% | +2.5% | +3.4% | +7.0% | -91.1% | -1.6% | -8.9% | -200.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -193.9% | – | – | |
| – | +94.2% | -36.8% | -22.3% | -22.7% | +14.5% | +282.6% | +124.4% | -5.1% | -8.9% | +154.5% | -27.1% | +23.0% | +12.4% | -76.5% | +220.6% | +13.4% | +39.4% | -37.9% | +61.7% | +19.0% | -8.5% | -4.4% | +14.9% | -23.6% | -6.0% | -20.6% | +12.6% | -37.2% | +3.8% | – | |
| – | +0.1% | +64.6% | +12.8% | -31.7% | +98.8% | +62.7% | +40.6% | -24.2% | +9.7% | -10.9% | +14.3% | +4.3% | +2.8% | +2.6% | +9.1% | +10.1% | -10.0% | -18.9% | +3.1% | +9.8% | +6.1% | -7.2% | +15.4% | -10.7% | +5.1% | +25.4% | -23.8% | +15.0% | +2.4% | – | |
| – | +38.6% | +6.4% | +0.8% | -29.3% | +74.6% | +104.2% | +70.2% | -15.3% | +1.1% | +67.4% | -15.4% | +15.8% | +8.1% | -51.2% | +78.4% | +12.0% | +21.1% | -32.1% | +38.4% | +17.5% | -5.6% | -4.2% | +13.8% | -19.0% | -2.6% | -6.5% | -3.4% | -19.1% | +3.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | +61.2% | -62.4% | -22.8% | +145.4% | -5.1% | +43.0% | +460.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -957,880.0% | – | – | +90.8% | +76.2% | +22.4% | -472.8% | – | – | – | – | -150.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.